Rubicon Organics Second Quarter 2025 Earnings: EPS: CA$0.012 (vs CA$0.008 loss in 2Q 2024)
Rubicon Organics (CVE:ROMJ) Second Quarter 2025 Results
Key Financial Results
Revenue: CA$15.0m (up 24% from 2Q 2024).
Net income: CA$773.2k (up from CA$454.2k loss in 2Q 2024).
Profit margin: 5.2% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue.
EPS: CA$0.012 (up from CA$0.008 loss in 2Q 2024).
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Rubicon Organics Earnings Insights
Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Pharmaceuticals industry in Canada.
Performance of the Canadian Pharmaceuticals industry.
The company's shares are up 3.8% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Rubicon Organics has 2 warning signs we think you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Qualys (QLYS) Wins Two Pwnie Awards at DEF CON for Groundbreaking OpenSSH Vulnerability Research
Qualys, Inc. (NASDAQ:QLYS) is one of the Qualys, Inc. (NASDAQ:QLYS) is one of the best midcap AI stocks to buy right now. On August 12, 2025, Qualys announced that its Threat Research Unit (TRU) received two Pwnie Awards at the DEF CON cybersecurity conference for its groundbreaking work uncovering critical OpenSSH vulnerabilities. The awards, 'Epic Achievement' and 'Best Remote Code Execution (RCE)', recognized Qualys for identifying CVE-2024-6387, the first pre-authentication RCE in OpenSSH in nearly two decades, and CVE-2025-26465, a man-in-the-middle attack affecting FreeBSD clients. The wins cement Qualys' status as a major player in vulnerability research. welcomia/ Alongside its ongoing threat research, Qualys expanded coverage within its Enterprise TruRisk Platform on August 12, 2025, issuing new vulnerability checks tied to Microsoft's latest Patch Tuesday update. While the company did not publish a formal press release, its research portal listed 98 vulnerabilities across 12 Microsoft security bulletins, with immediate support deployed for customer environments. The update underscores Qualys' operational emphasis on rapid detection and remediation, reinforcing its reputation for delivering same-day protections aligned with major vendor disclosures. Qualys is a U.S.-based provider of cloud-native IT, security, and compliance solutions. Its platform is used by global enterprises to manage vulnerabilities, ensure policy compliance, protect against threats, and inventory digital assets across hybrid environments. While we acknowledge the potential of QLYS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
Canaccord Raises Zeta Global (ZETA)Price Target on Strong Q2 and Expanding AI Adoption
Zeta Global Holdings Corp. (NASDAQ:ZETA) is one of the Zeta Global Holdings Corp. (NASDAQ:ZETA) is one of the best midcap AI stocks to buy right now. On August 6, 2025, Canaccord Genuity maintained its 'Buy' rating on Zeta Global and raised the price target from $26 to $28 on the back of a strong second quarter. Analyst David Hynes emphasized confidence in Zeta's OneZeta platform adoption and AI-aligned 'Zeta Answers' product, citing these as key drivers for expanding engagement. Source: pixabay Despite competitive pressures, Canaccord highlighted Zeta's growth momentum and execution, including revenue growth, EBITDA gains, and accelerating free cash flow. The firm's message was clear: business strength and AI innovation justify an elevated outlook. Zeta Global is a New York–based marketing technology company delivering an omnichannel, AI-enhanced customer acquisition and engagement suite. Its Zeta Marketing Platform (ZMP) uses vast identity and behavioral datasets to enable predictive, data-driven marketing, and it's gaining traction across enterprise clients. While we acknowledge the potential of ZETA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and .
Yahoo
6 hours ago
- Yahoo
UiPath (PATH) Launches Generative Extractions to Automate Complex Document Processing
UiPath Inc. (NYSE:PATH) is one of the UiPath Inc. (NYSE:PATH) is one of the best midcap AI stocks to buy right now. On August 1, 2025, UiPath announced the general availability of its new Generative Extractions capability for the Intelligent Document Processing (IXP) platform. The release enables users to automate the processing of unstructured and complex documents using generative AI. This includes parsing multi-table layouts, freeform text, embedded graphics, and other non-standard formats that traditional document automation tools often fail to handle effectively. The feature is now live in the U.S. and Europe, with public previews rolled out to customers in Canada, Australia, and Japan. This expansion marks a major step forward in UiPath's strategy to integrate large language model capabilities across its platform. By bringing generative document understanding to production environments, the company is positioning its platform not just for routine automation, but for high-complexity, high-volume enterprise workflows. With many global organizations still struggling to extract structured insights from PDFs, scans, and multi-modal documents, this feature directly addresses one of the most persistent gaps in automation. UiPath is a New York-based enterprise automation software company known for its robotic process automation (RPA) platform. UiPath is actively transitioning toward agentic automation, mixing deterministic RPA workflows with generative AI and AI agents. They've introduced tools like Agent Builder and launched the UiPath Platform for Agentic Automation, which orchestrates AI agents, robots, and humans into a unified intelligent system. While we acknowledge the potential of PATH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
